Gender and effects of a common genetic variant in the NOS1 regulator NOS1AP on cardiac repolarization in 3761 individuals from two independent populations

International Journal of Epidemiology

Volumn 37, Issue 5, 2008, Pages 1132-1141

  Tobin, Martin D ^a   Kähönen, Mika ^b   Braund, Peter ^c   Nieminen, Tuomo ^d   Hajat, Cother ^a   Tomaszewski, Maciej ^c   Viik, Jari ^d   Lehtinen, Rami ^b,e   Ng, G Andre ^c   Macfarlane, Peter W ^f   Burton, Paul R ^a   Lehtimäki, Terho ^b,g   Samani, Nilesh J ^c  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b TAMPERE UNIVERSITY HOSPITAL   (Finland)

^c UNIVERSITY OF LEICESTER   (United Kingdom)

^d TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^e TAMPERE UNIVERSITY OF APPLIED SCIENCES   (Finland)

^f UNIVERSITY OF GLASGOW   (United Kingdom)

^g UNIVERSITY OF TAMPERE MEDICAL SCHOOL   (Finland)

Author keywords

Cardiac repolarization; Gender; Genetic association; NOS1AP; QTc

Indexed keywords

ADAPTOR PROTEIN; NEURONAL NITRIC OXIDE SYNTHASE; NEURONAL NITRIC OXIDE SYNTHASE 1 ADAPTOR PROTEIN; PROTEIN NOS1AP; REGULATOR PROTEIN; UNCLASSIFIED DRUG;

CARDIOVASCULAR DISEASE; GENDER RELATIONS; GENETIC VARIATION; RISK FACTOR;

ADOLESCENT; ADULT; AGED; ALLELE; ARTICLE; CONTROLLED STUDY; EXERCISE TEST; FAMILY STUDY; FEMALE; FINLAND; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HEART ARRHYTHMIA; HEART REPOLARIZATION; HUMAN; INDIVIDUALITY; MAJOR CLINICAL STUDY; MALE; PATIENT REFERRAL; POPULATION RESEARCH; PRIORITY JOURNAL; QT INTERVAL; QT PROLONGATION; REST; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; UNITED KINGDOM;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADULT; ALLELES; ELECTROCARDIOGRAPHY; EXERCISE; FEMALE; FINLAND; GENOTYPE; GREAT BRITAIN; HEALTH SURVEYS; HEART; HEART RATE; HUMANS; LINEAR MODELS; LONG QT SYNDROME; MALE; MIDDLE AGED; SEX FACTORS; VARIATION (GENETICS);

EID: 53349100962     PISSN: 03005771     EISSN: 14643685     Source Type: Journal    
DOI: 10.1093/ije/dyn091     Document Type: Article

References (55)

1. Priori SG, Napolitano C. Genetics of cardiac arrhythmias and sudden cardiac death. Ann N Y Acad Sci 2004;1015:96-110.
2. Patel ND, Singh BK, Mathew ST. The heterogeneous spectrum of the long QT syndrome. Eur J Intern Med 2006;17:235-40.
3. Dekker JM, Crow RS, Hannan PJ, Schouten EG, Folsom AR. Heart rate-corrected QT interval prolongation predicts risk of coronary heart disease in black and white middle-aged men and women: The ARIC study. J Am Coll Cardiol 2004;43:565-71.
4. Schouten EG, Dekker JM, Meppelink P, Kok FJ, Vandenbroucke JP, Pool J. QT interval prolongation predicts cardiovascular mortality in an apparently healthy population. Circulation 1991;84:1516-23.
5. Elming H, Holm E, Jun L et al. The prognostic value of the QT interval and QT interval dispersion in all-cause and cardiac mortality and morbidity in a population of Danish citizens. Eur Heart J 1998;19:1391-400.
6. Yap YG, Camin AJ. Drug induced QT prolongation and torsades de pointes. Heart 2003;89:1363-72.
7. U.S. Department of Health and Human Services Food and Drug Administration. Guidance for Industry: E14 Clinical Evaluation of QT/ QTc Interval Prolongation and Proarrhythmic Potential for Non-Antiarrhythmic Drugs. Rockville, MD: Food and Drug Administration, 2005;pp.1-16.
8. De Pond F, Poluzzi E, Montanaro N, Ferguson J. QTc and psychotropic drugs. Lancet 2000;356:75-76.
9. Roden DM. Drug-induced prolongation of the QT interval. N Engl J Med 2004;350:1013-22.
10. Kannankeril PJ, Roden DM. Drug-induced long QT and torsade de pointes: recent advances. Curr Opin Cardiol 2007;22:39-43.
11. Rautaharju PM, Zhou SH, Wong S et al. Sex differences in the evolution of the electrocardiographic QT interval with age. Can J Cardiol 1992;8:690-95.
12. Makkar RR, Fromm BS, Steinman RT, Meissner MD, Lehmann MH. Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs. Jama 1993;270:2590-97.
13. Ebert SN, Liu XK, Woosley RL. Female gender as a risk factor for drug-induced cardiac arrhythmias: Evaluation of clinical and experimental evidence. J Womens Health 1998;7:547-57.
14. Lehmann MH, Hardy S, Archibald D, Quart B, MacNeil DJ. Sex difference in risk of torsade de pointes with d,l-sotalol. Circulation 1996; 94:2535-41.
15. Sauer AJ, Moss AJ, McNitt S et al. Long QT syndrome in adults. J Am Coll Cardiol 2007;49:329-37.
16. Tester DJ, Ackerman MJ. Postmortem long QT syndrome genetic testing for sudden unexplained death in the young. J Am Coll Cardiol 2007; 49:240-46.
17. Schwartz PJ, Priori SG, Spazzolini C et al. Genotype-phenotype correlation in the long-QT syndrome: Genespecific triggers for life-threatening arrhythmias. Circulation 2001;103:89-95.
18. Walker BD, Krahn AD, Klein GJ, Skanes AC, Yee R. Burst bicycle exercise facilitates diagnosis of latent long QT syndrome. Am Heart J 2005;150:1059-63.
19. Swan H, Viitasalo M, Piippo K, Laitinen P, Kontula K, Toivonen L. Sinus node function and ventricular repolarization during exercise stress test in long QT syndrome patients with KvLQT1 and HERG potassium channel defects. J Am Coll Cardiol 1999;34:823-29.
20. Magnano AR, Holleran S, Ramakrishnan R, Reiffel JA, Bloomfield DM. Autonomic nervous system influences on QT interval in normal subjects. J Am Coll Cardiol 2002;39:1820-26.
21. Chauhan VS, Krahn AD, Walker BD, Klein GJ, Skanes AC, Yee R. Sex differences in QTc interval and QT dispersion: Dynamics during exercise and recovery in healthy subjects. Am Heart J 2002;144:858-64.
22. Wang Q, Shen J, Splawski I et al. SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome. Cell 1995;80 805-11.
23. Vatta M, Ackerman MJ, Ye B et al. Mutant caveolin-3 induces persistent late sodium current and is associated with long-QT syndrome. Circulation 2006;114:2104-12.
24. Friedlander Y, Lapidos T, Sinnreich R, Kark JD. Genetic and environmental sources of QT interval variability in Israeli families: the kibbutz settlements family study. Clin Genet 1999;56 200-9.
25. Newton-Cheh C, Larson MG, Corey DC et al. QT interval is a heritable quantitative trait with evidence of linkage to chromosome 3 in a genome-wide linkage analysis: The Framingham Heart Study. Heart Rhythm 2005;2:277-84.
26. Busjahn A, Knoblauch H, Faulhaber HD et al. QT interval is linked to 2 long-QT syndrome loci in normal subjects. Circulation 1999; 99:3161-64.
27. Arking DE, Chugh SS, Chakravarti A, Spooner PM. Genomics in sudden cardiac death. Circ Res 2004; 94:712-23.
28. Arking DE, Pfeufer A, Post W et al. A common genetic variant in the NOSI regulator NOSIAP modulates cardiac repolarization. Nat Genet 2006;38:644-51.
29. Akyol M, Jalilzadeh S, Sinner MF et al. The common non-synonymous variant G38S of the KCNE1-(minK)-gene is not associated to QT interval in Central European Caucasians: Results from the KORA study. Eur Heart J 2007;28:305-9.
30. Pfeufer A, Jalilzadeh S, Perz S et al. Common variants in myocardial ion channel genes modify the QT interval in the general population: Results from the KORA study. Circ Res 2005;96 693-701.
31. Aarnoudse AJ, Newton-Cheh C, de Bakker PI et al. Common NOSIAP variants are associated with a prolonged QTc interval in the Rotterdam Study. Circulation 2007;116:10-16.
32. Post W, Shen H, Damcott C et al. Associations between genetic variants in the NOSIAP (CAPON) gene and cardiac repolarization in the old order Amish. Hum Hered 2007;64:214-19.
33. Segalat L, Grisoni K, Archer J, Vargas C, Bertrand A, Anderson JE. CAPON expression in skeletal muscle is regulated by position, repair, NOS activity, and dystrophy. Exp Cell Res 2005;302:170-79.
34. Xu B, Wratten N, Charych EI, Buyske S, Firestein BL, Brzustowicz LM. Increased expression in dorsolateral prefrontal cortex of CAPON in schizophrenia and bipolar disorder. PLoS Med 2005;2:e263.
35. Tobin MD, Raleigh SM, Newhouse S et al. Association of WNK1 gene polymorphisms and haplotypes with ambulatory blood pressure in the general population. Circulation 2005;112:3423-29.
36. Macfarlane PW, Devine B, Clarke E. The University of Glasgow (Uni-G) ECG analysis program. Comput Cardiol 2005;32:451-54.
37. Luo S, Michler K, Johnston P, Macfarlane PW. A comparison of commonly used QT correction formulae: The effect of heart rate on the QTc of normal ECGs. J Electrocardiol 2004;37 (Suppl.):81-90.
38. Nieminen T, Lehtinen R, Viik J et al. The Finnish Cardiovascular Study (FINCAVAS): Characterising patients with high risk of cardiovascular morbidity and mortality. BMC Cardiovasc Disord 2006;6:9.
39. Burton PR, Tiller KJ, Gurrin LC, Cookson WO, Musk AW, Palmer LJ. Genetic variance components analysis for binary phenotypes using generalized linear mixed models (GLMMs) and Gibbs sampling. Genet Epidemiol 1999;17:118-40.
40. Spiegelhalter D, Thomas A, Best N. WinBUGS Version 1.4 - User Manual Cambridge: MRC Biostatistics Unit, 2003.
41. Burton PR, Tobin MD, Hopper JL. Key concepts in genetic epidemiology. Lancet 2005;366:941-51.
42. Burton P, Gurrin L, Sly P. Extending the simple linear regression model to account for correlated responses: An introduction to generalized estimating equations and multi-level mixed modelling. Stat Med 1998; 17:1261-91.
43. Nyholt DR. ssSNPer: Identifying statistically similar SNPs to aid interpretation of genetic association studies. Bioinformatics 2006;22:2960-61.
44. Wang P, Dai M, Xuan W et al. SNP Function Portal: A web database for exploring the function implication of SNP alleles. Bioinformatics 2006;22:e523-29.
45. Yue P, Melamud E, Moult J. SNPs3D: Candidate gene and SNP selection for association studies. BMC Bioinformatics 2006;7:166.
46. Hattersley AT, McCarthy MI. What makes a good genetic association study? Lancet 2005;366:1315-23.
47. The Wellcome Trust Case Control Consrtium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007; 447:661-78.
48. Davey Smith G, Ebrahim S. 'Mendelian randomization': Can genetic epidemiology contribute to understanding environmental determinants of disease? Int J Epidemiol 2003;32:1-22.
49. Tobin MD. Minelli C, Burton PR, Thompson JR. Commentary: Development of Mendelian randomization: From hypothesis test to 'Mendelian deconfounding'. Int J Epidemiol 2004;33:26-29.
50. Su HM, Chiu HC, Lin TH, Voon WC, Liu HW, Lai WT. Longitudinal study of the ageing trends in QT interval and dispersion in healthy elderly subjects. Age Ageing 2006;35:636-38.
51. Lehtinen AB, Newton-Cheh C, Ziegler JT et al. Association of NOSIAP genetic variants with QT interval duration in families from the Diabetes Heart Study. Diabetes 2008; 57:1108-14.
52. Bai CX, Kurokawa J, Tamagawa M, Nakaya H, Furukawa T. Nontranscriptional regulation of cardiac repolarization currents by testosterone. Circulation 2005;112:1701-10.
53. Ayers NA, Kapas L, Krueger JM. The inhibitory effects of N omega-nitro-L-arginine methyl ester on nitric oxide synthase activity vary among brain regions in vivo but not in vitro. Neurochem Res 1997;22:81-86.
54. Beaton DA, Li D, Almond SC et al. Gene transfer of neuronal nitric oxide synthase into intracardiac Ganglia reverses vagal impairment in hypertensive rats. Hypertension 2007;49:380-88.
55. Casadei B. The emerging role of neuronal nitric oxide synthase in the regulation of myocardial function. Exp Physiol 2006;91 943-55.